At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 32 enrolled
Drug / intervention
CS-1103 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 1a, Randomized, Double-Blind, Placebo-Controlled, Single Center Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CS-1103 Following Single, Ascending Intravenous Dose Administration in Healthy Participants
In Brief
A Phase 1 clinical trial evaluating CS-1103 and Sterile Saline for Substance Use Disorders and 2 related conditions. Completed, enrolled 32 participants across 1 site.
Detailed Summary
The purpose of this Phase 1a study is to evaluate safety, tolerability, and pharmacokinetics (PK) of single, ascending doses of CS-1103, administered by intravenous (IV) infusion in healthy participants.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)
Timeline
Phase 1CompletedFinished
202420252026
Enrollment StartFeb 2024
First PostedMar 2024
Primary CompletionMay 2024
Study CompletionJun 2024
TodayJul 2026
First PostedMar 19, 2024
Enrollment StartFeb 7, 2024
Primary CompletionMay 30, 2024
Study CompletionJun 6, 2024
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 2.3 years ago
Interventions
CS-1103drug
CS-1103 for infusion
Sterile Salinedrug
Sterile Saline for Injection